7VF-24417-04043
4 vaccinations
2 coded responses
53 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 802 / CO
- Registered
- 2020-12-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
3KV-33168-49850
Child or adolescent in my care · Male · 2022-07-14
5DZ-94491-07994
Child or adolescent in my care · Male · 2022-11-30
Timeline
-
2020-12-17
Registered in v-safe
-
2020-12-17
Dose 1 — Pfizer-BioNTech
- 2020-12-17
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-23
- 2020-12-24
- 2020-12-31
-
2021-01-07
Dose 2 — Pfizer-BioNTech
- 2021-01-07
-
2021-01-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-08
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-01-09
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · HeadacheAdult check-in
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-21
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-04-08
- 2021-07-08
-
2021-09-29
Dose 3 — Pfizer-BioNTech
- 2021-09-29
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work or attend schoolAdult check-in
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work or attend schoolAdult check-in
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
-
2021-10-13
Survey response — day 14, dose 3MedDRA: Body temperature increased, Chills — Feeling: FairFree text: Intermittent chills, low grade fever (max 99.8)MedDRA releases: 2024-11 · check-in free text available
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-11
- 2021-12-29
- 2022-03-30
- 2022-09-29
-
2022-10-19
Dose 4 — Pfizer-BioNTech
-
2022-10-20
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-10-21
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2022-10-22
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-10-23
- 2022-10-24
- 2022-10-25
-
2022-10-26
Health check-in — day 7, dose 4Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-11-02
Survey response — day 14, dose 4MedDRA: Cough, Oropharyngeal pain, Pyrexia, Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend schoolFree text: Fever, upper respiratory infection, sore throat, cough.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-09
- 2022-11-16
- 2022-11-23
- 2022-11-30
- 2023-01-18
- 2023-04-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
| 4 | 2022-10-19 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-08 | priority 2/3 | |
| 2021-01-09 | priority 2/3 |
Free text
Release 10 — day 14, dose 3
Symptoms: Intermittent chills, low grade fever (max 99.8)
Release 12 — day 14, dose 4
Symptoms: Fever, upper respiratory infection, sore throat, cough.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Body temperature increased | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release